Browsing: global

The Consortium for Biomedical Research and Artificial Intelligence in Neurodegeneration (C-BRAIN), a global collaboration of academic researchers, pharmaceutical companies, and philanthropic organizations of which Washington University School of Medicine in St. Louis is a founding member, today launched three open-source AI tools to accelerate research aimed at developing new treatments for Alzheimer’s disease and other…

Obesity is no longer viewed simply as an issue of body weight or personal discipline. Today, it is recognized as a chronic metabolic disease involving complex interactions between hormones, the nervous system, inflammation, and the body’s energy regulation pathways. As obesity rates continue to rise worldwide, so does the burden of associated conditions including type…

Cancer is no longer a disease that afeels distant. Almost every family today knows someone who has battled it, a parent, sibling, colleague or friend. The numbers behind that experience are becoming even more alarming.The World Health Organization (WHO) has warned that the world could see nearly 35 million new cancer cases every year by…

The pressure on Amgen’s Tavneos is ratcheting up ahead of a potential hearing about the future of the drug. Since the FDA proposed withdrawing approval in April, a journal has retracted a key paper on the rare disease drug, the European Medicines Agency has recommended revoking authorization and Amgen’s Japanese partner has reportedly urged doctors…